Live Chat

Trade MerckCo USA MRK

Sell
 Buy

MerckCo live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
date Close change Change (%) Open High Low

Latest news

Bitcoin and Trump crypto market trends and impact.
Vanessa L 2025 Jan 24, 11:20

Trump Crypto Analysis and Insights

Cryptocurrencies
Close-up of gold bars on nugget grains, symbolizing metal prices today and commodity gold.
Vanessa L 2025 Jan 24, 10:40

Commodity Gold and Metal Prices Today

Forex Gold Commodities
USD to JPY forecast with currency chart showing forex market trends.
Vanessa L 2025 Jan 24, 10:30

BoJ Interest Rate Hike ; USD to JPY Forecast

Forex JPY USD
A graph showing us stock futures mildly decline after S&P 500 record close.
Vanessa L 2025 Jan 24, 06:30

US Stock Futures Decline After S&P 500 Record Close

Shares Stocks US500
Frances Wang 2025 Jan 23, 16:00

Tesla stock prediction 2025: forecast for the tesla share price

TSLA Stocks Shares
Frances Wang 2025 Jan 23, 16:00

Zuckerberg sold stock: He Sells $2 Billion in Meta Stock Amid AI Push

Stocks
Frances Wang 2025 Jan 23, 16:00

Financial compensation news: Car compensation may affect working people

CFD Trading
Tommy Yap 2025 Jan 23, 16:00

Morning Note: S&P 500 Reaches Record High Amid Trump’s Rate and Oil Policy Hints

Morning Note S&P 500 Oil

Info

Spread

0.60

Spread (%)

0.6301 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

244439105536

Shares Outstanding

2529639936

Earnings Date (Next)

2021-06-03

instr__dividend_date

2025-01-08

instr__ex_dividend_date

2024-12-16

instr__forward_annual_dividend_rate

3.24

instr__forward_annual_dividend_yield

0.0335

EPS

4.78

Learn more about this instrument

MerckCo USA Merck & Company Inc
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. vIt has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications. It also has licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments
Trustpilot
Live Chat